BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.
Go back to BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.| Becton Dickinson (NYSE: BDX) | Delayed: 143.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $143.92 | 52 Week High | $181.76 | |||
| Open | $143.92 | 52 Week Low | $129.50 | |||
| Day High | $143.92 | P/E | 30.69 | |||
| Day Low | $143.92 | EPS | $4.69 | |||
| Volume | 152 | |||||
